Raul Cordoba: Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma

Raul Cordoba shared on X:

“HOT OFF THE PRESS!

Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.”

Read further
Source: Raul Cordoba/X

Raúl Córdoba Mascuñano, MD, PhD is a specialist in hematology and hemotherapy. He is the Coordinator of the Lymphoma Unit at University Hospital Fundación Jiménez Díaz, Madrid, Spain. He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.